Dawson James agreement spells out a minimum 15 million capital raise as a trigger for DJ to get paid in preferred shares congruent with national exchange listing.
Andrews agreement has 15 million dollar capital raise as an accelerator. Coincidence? Probably not.
We know INDs require funding. Inventiv would not come on board without means to funding. IR debacle delayed much. Any entity funding INDs would want those monies going strictly to IND effort and not convoluted with business model of licensing and clinics.
Therefore, an entity for IND efforts (possibly ICBS research subsidiary) must be separated from SVFC parent. This is simply logical. One way to place underlying value on the parent is to distribute or dividend shares of a new entity. This also minimizes shorting efforts as distribution day approaches.
The filings also clearly show the CD holders have been working with the company. Meaning they would also work with company during potential spin off phase. With a cash supply and high profile attachments pursuing multiple stem cell INDs using a very efficient extraction method could yield much investor excitement and market valuations of said entity comparable with others 50-100 mil...
Speculation fits the action and this course has been used very effectively by other micro stocks in the past. In my opinion. ;)
News 
Market Data 
Discover 
